Understanding the latest FDA guidance on investigational new drugs for cell and gene therapy
On the 28th January 2020 we saw the FDA update its guidance for industry regarding chemistry, manufacturing, and control (CMC) on the application of (INDs) for cell and gene therapy, including assurance of clonality and stable cell line development. Innovation driving gene therapy Within this document the FDA provides guidance to the industry and to …